Novavax (NVAX) Earnings Date, Estimates & Call Transcripts $8.25 +0.06 (+0.73%) Closing price 04:00 PM EasternExtended Trading$8.28 +0.04 (+0.42%) As of 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Novavax Latest Earnings SummaryUpcoming Q4 Earnings DateMay. 8Before Market OpensEstimatedActual EPS (Nov. 12) -$0.76 Beat By $0.07 Consensus EPS (Nov. 12) -$0.83 Novavax released Q3 2024 earnings on November 12, 2024, reporting an EPS of -$0.76, which beat analysts' consensus estimates of -$0.83 by $0.07. Quarterly revenue fell 54.8% year-over-year to $84.51 million, above analyst estimates of $65.80 million. With a trailing EPS of -$2.26, Conference CallConference Call TranscriptEarnings Press ReleaseEarnings Slide DeckPowered by NVAX Upcoming EarningsNovavax's next earnings date is estimated for Thursday, May 8, 2025, based off prior year's reporting schedules. Get Novavax Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Novavax and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataNVAX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.NVAX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Novavax Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.63-$0.49-$0.56Q2 20252$0.44$0.65$0.55Q3 20252-$0.40-$0.37-$0.39Q4 20252-$0.57-$0.15-$0.36FY 20258-$1.16-$0.36-$0.76Q1 20261-$0.19-$0.19-$0.19Q2 20261$0.07$0.07$0.07Q3 20261$0.06$0.06$0.06 Novavax Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/8/2025(Estimated)-------11/12/2024Q3 2024-$0.83-$0.76+$0.07-$0.76$65.80M$84.51M8/8/2024Q2 2024$1.82$0.99 -$0.83$0.99$458.57M$415.50M5/10/2024Q1 2024-$1.04-$1.05 -$0.01-$1.05$71.32M$93.90M2/28/2024Q4 2023-$0.49-$1.44 -$0.95-$1.44$310.96M$291.34M11/9/2023Q3 2023-$1.82-$1.26+$0.56-$1.26$171.04M$187.00M8/8/2023Q2 2023-$1.24$0.58+$1.82$0.58$264.16M$424.40M5/9/2023Q1 2023-$3.38-$3.41 -$0.03-$3.41$94.52M$81.00M2/28/2023Q4 2022-$0.92-$2.28 -$1.36-$2.28$383.14M$357.40M More Earnings Resources from MarketBeat Related Companies IONS Earnings FOLD Earnings LGND Earnings BCRX Earnings DVAX Earnings GERN Earnings CLDX Earnings MNKD Earnings MYGN Earnings INVA Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Hims & Hers Earnings Could Be a Game Changer—What to Do NowAnalysts See Buying Opportunity in NVIDIA Before EarningsAirbnb's Earnings: Sky High Results, Grounded Guidance?Is Coinbase Stock a Buy After Earnings?CVS Health: Earnings Beat Ignites Stock RallyQualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?Cirrus Logic Upgraded After Q3 Earnings Beat—More Gains Ahead? This page (NASDAQ:NVAX) was last updated on 2/18/2025 by MarketBeat.com Staff From Our PartnersNew powers for ElonAccording to one Boston think tank, which has connections in almost every major Wall Street institution, Elon ...Altimetry | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored50-year legend: Here’s exact day stocks will crashBig Study Shows Stocks Extremely Likely to Crash in 2026? Legendary quant analyst Marc Chaikin says in 50 y...Chaikin Analytics | SponsoredTrump's Nvidia Nightmare?Something strange is happening in Silicon Valley... Microsoft, Google, and Amazon are making unusual prepar...Banyan Hill Publishing | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored(1) Elon Musk’s Final Project REVEALEDThe world’s richest man has an ace up his sleeve. You see, while everyone is talking about Elon Musk’s plan...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novavax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Novavax With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.